Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Year and a half

<< Previous

Bullboard Posts

Next >>

Comment by NSX001on Oct 17, 2022 12:00pm

145 Views

Post# 35029095

RE:Year and a half

Good morning JACKTHE BEAR,

Yes, this story is verging on the insane, a year and a half just to review an existing product, holy sh*t. Do they have just one person on staff reviewing the documents, making coffee, ordering pencils (if they still use pencils) and answering the phones?

NSX001

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property